COVID Vaccine Recommendations

Order byBest matchMost fresh

FDA, COVID and vaccine

Top News

Overview

Impacts

FDA Panel Recommends Monovalent COVID Vaccine for Next Season

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 lineage, although members disagreed slightly about which specific strain should be included.

MedPage Today · 46m

· 1d · on MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

· 1d

FDA offers new guidelines to shift COVID vaccine focus to high-risk groups

FDA panel is split on updates to COVID shots as questions loom for fall vaccinations

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and winter — even as a new Trump administration policy has thrown into question w...

· 1h

· 1d

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 8h

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

· 1d

New Trump vaccine policy limits access to COVID shots

4hon MSN

Changes are happening around COVID-19 vaccines: Here's what to know

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

1don MSN

Mass. residents say they're not worried by new COVID vaccine guidelines

New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get at least one vaccine per year, with those in higher-0

Federal officials may limit recommendations for COVID vaccine

New requirements for clinical testing of vaccines, announced this month, may delay the availability of shots that had formerly been updated annually without complicated trials.

1don MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

2don MSN

Trump Administration Toughens Requirements for Covid Vaccine Approval

Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.

2don MSN

FDA to limit covid shot approval to elderly, those with medical conditions

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.